Disclosures for "Effects of ocrelizumab on NK cell activation in Relapsing Multiple Sclerosis")
-
Dr. Abbadessa has nothing to disclose.
-
Dr. Bruzzaniti has nothing to disclose.
-
Dr. Miele has nothing to disclose.
-
Dr. Piemonte has nothing to disclose.
-
Dr. Lepore has nothing to disclose.
-
Elisabetta Signoriello has nothing to disclose.
-
Giacomo Lus has nothing to disclose.
-
Giuseppe Matarese has nothing to disclose.
-
Mario Galgani has nothing to disclose.
-
Prof. Bonavita has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis, Biogen, Mylan, Sanofi. Prof. Bonavita has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mylan, Novartis.